(C025) Amundi MSCI China II - Ratings and Ratios
Exchange: XETRA •
Country: Germany •
Currency: USD •
Type: Etf •
ISIN: LU1033694107
Chinese, Stocks, Equities, Investments
Description: C025 Amundi MSCI China II
N/A URL: http://www.amundi.com Index: Morningstar China TME NR USD
Additional Sources for C025 ETF
C025 ETF Overview
| Market Cap in USD | 187m |
| Category | China Equity |
| TER | 0.25% |
| IPO / Inception | 2023-03-10 |
C025 ETF Ratings
| Growth Rating | 14.7 |
| Fundamental | - |
| Dividend Rating | 55.9 |
| Rel. Strength | -5.48 |
| Analysts | - |
| Fair Price Momentum | 142.37 USD |
| Fair Price DCF | - |
C025 Dividends
| Dividend Yield 12m | 2.17% |
| Yield on Cost 5y | 2.18% |
| Annual Growth 5y | 13.93% |
| Payout Consistency | 100.0% |
| Payout Ratio | % |
C025 Growth Ratios
| Growth Correlation 3m | 84.9% |
| Growth Correlation 12m | 47.6% |
| Growth Correlation 5y | 22.5% |
| CAGR 5y | 1.33% |
| CAGR/Max DD 5y | 0.05 |
| Sharpe Ratio 12m | 0.04 |
| Alpha | 12.37 |
| Beta | 0.343 |
| Volatility | 16.81% |
| Current Volume | 1.3k |
| Average Volume 20d | 0.1k |
| Stop Loss | 144.9 (-3.5%) |
What is the price of C025 shares?
As of July 09, 2025, the stock is trading at USD 150.18 with a total of 1,346 shares traded.
Over the past week, the price has changed by +1.21%, over one month by +2.92%, over three months by +15.38% and over the past year by +23.23%.
As of July 09, 2025, the stock is trading at USD 150.18 with a total of 1,346 shares traded.
Over the past week, the price has changed by +1.21%, over one month by +2.92%, over three months by +15.38% and over the past year by +23.23%.
Is Amundi MSCI China II a good stock to buy?
Neither. Based on ValueRay´s Analyses, Amundi MSCI China II is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 14.71 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of C025 is around 142.37 USD . This means that C025 is currently overvalued and has a potential downside of -5.2%.
Neither. Based on ValueRay´s Analyses, Amundi MSCI China II is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 14.71 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of C025 is around 142.37 USD . This means that C025 is currently overvalued and has a potential downside of -5.2%.
Is C025 a buy, sell or hold?
Amundi MSCI China II has no consensus analysts rating.
Amundi MSCI China II has no consensus analysts rating.
What are the forecasts for C025 share price target?
According to our own proprietary Forecast Model, C025 Amundi MSCI China II will be worth about 157.5 in July 2026. The stock is currently trading at 150.18. This means that the stock has a potential upside of +4.89%.
According to our own proprietary Forecast Model, C025 Amundi MSCI China II will be worth about 157.5 in July 2026. The stock is currently trading at 150.18. This means that the stock has a potential upside of +4.89%.
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 157.5 | 4.9% |